A recent study found that the combination of Saikosaponin b1 nanodrugs and antioxidant MnO2 removed excessive H2O2 and reduced hypoxia-induced TGF-β1, ultimately treating liver fibrosis [54]. This evidence concerns the gene TGFB1 and Hepatic fibrosis.